ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives

April 17, 1981

In Brief: Laird Myers Heads AACE, George Hill President Elect; Cal Tech’s Hood Receives Bertner Award

March 1, 1985

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

Group Chairs: Research In “Crisis” ASCO Says NCTN Budgets Cut By 40 Percent, Warns of “Dangerous Disruption of Cancer Care”

April 4, 2014